Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Interplay between Autophagy, Exosomes and HIV-1 Associated Neurological Disorders: New Insights for Diagnosis and Therapeutic Applications.

Ojha CR, Lapierre J, Rodriguez M, Dever SM, Zadeh MA, DeMarino C, Pleet ML, Kashanchi F, El-Hage N.

Viruses. 2017 Jul 6;9(7). pii: E176. doi: 10.3390/v9070176. Review.

2.

Intranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation.

Rodriguez M, Lapierre J, Ojha CR, Kaushik A, Batrakova E, Kashanchi F, Dever SM, Nair M, El-Hage N.

Sci Rep. 2017 May 12;7(1):1862. doi: 10.1038/s41598-017-01819-9.

3.

Correction: Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining.

Beckta JM, Dever SM, Gnawali N, Khalil A, Sule A, Golding SE, Rosenberg E, Narayanan A, Kehn-Hall K, Xu B, Povirk LF, Valerie K.

Oncotarget. 2016 Sep 6;7(36):58716. doi: 10.18632/oncotarget.11846. No abstract available.

4.

Mammalian microRNA: an important modulator of host-pathogen interactions in human viral infections.

Ojha CR, Rodriguez M, Dever SM, Mukhopadhyay R, El-Hage N.

J Biomed Sci. 2016 Oct 26;23(1):74. Review.

5.
6.

Electro-Magnetic Nano-Particle Bound Beclin1 siRNA Crosses the Blood-Brain Barrier to Attenuate the Inflammatory Effects of HIV-1 Infection in Vitro.

Rodriguez M, Kaushik A, Lapierre J, Dever SM, El-Hage N, Nair M.

J Neuroimmune Pharmacol. 2017 Mar;12(1):120-132. doi: 10.1007/s11481-016-9688-3. Epub 2016 Jun 10.

7.

Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining.

Beckta JM, Dever SM, Gnawali N, Khalil A, Sule A, Golding SE, Rosenberg E, Narayanan A, Kehn-Hall K, Xu B, Povirk LF, Valerie K.

Oncotarget. 2015 Sep 29;6(29):27674-87. doi: 10.18632/oncotarget.4876. Erratum in: Oncotarget. 2016 Sep 6;7(36):58716.

8.

Fluorescently-labeled RNA packaging into HIV-1 particles: Direct examination of infectivity across central nervous system cell types.

Xu R, El-Hage N, Dever SM.

J Virol Methods. 2015 Nov;224:20-9. doi: 10.1016/j.jviromet.2015.07.023. Epub 2015 Aug 10.

9.

Differing roles of autophagy in HIV-associated neurocognitive impairment and encephalitis with implications for morphine co-exposure.

Dever SM, Rodriguez M, Lapierre J, Costin BN, El-Hage N.

Front Microbiol. 2015 Jul 6;6:653. doi: 10.3389/fmicb.2015.00653. eCollection 2015.

10.

BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection.

Guendel I, Meltzer BW, Baer A, Dever SM, Valerie K, Guo J, Wu Y, Kehn-Hall K.

Virol J. 2015 Mar 6;12:40. doi: 10.1186/s12985-015-0266-8.

11.

HIV-1 and morphine regulation of autophagy in microglia: limited interactions in the context of HIV-1 infection and opioid abuse.

El-Hage N, Rodriguez M, Dever SM, Masvekar RR, Gewirtz DA, Shacka JJ.

J Virol. 2015 Jan 15;89(2):1024-35. doi: 10.1128/JVI.02022-14. Epub 2014 Oct 29.

12.

Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphine.

El-Hage N, Rodriguez M, Podhaizer EM, Zou S, Dever SM, Snider SE, Knapp PE, Beardsley PM, Hauser KF.

AIDS. 2014 Jun 19;28(10):1409-19. doi: 10.1097/QAD.0000000000000291.

13.

Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals.

Dever SM, Costin BN, Xu R, El-Hage N, Balinang J, Samoshkin A, O'Brien MA, McRae M, Diatchenko L, Knapp PE, Hauser KF.

AIDS. 2014 Jan 2;28(1):19-30. doi: 10.1097/QAD.0000000000000113.

14.

Ethanol regulation of serum glucocorticoid kinase 1 expression in DBA2/J mouse prefrontal cortex.

Costin BN, Dever SM, Miles MF.

PLoS One. 2013 Aug 22;8(8):e72979. doi: 10.1371/journal.pone.0072979. eCollection 2013.

15.

The Influence of Hypoxia and pH on Bioluminescence Imaging of Luciferase-Transfected Tumor Cells and Xenografts.

Khalil AA, Jameson MJ, Broaddus WC, Lin PS, Dever SM, Golding SE, Rosenberg E, Valerie K, Chung TD.

Int J Mol Imaging. 2013;2013:287697. doi: 10.1155/2013/287697. Epub 2013 Jul 7.

16.

A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia.

El-Hage N, Dever SM, Podhaizer EM, Arnatt CK, Zhang Y, Hauser KF.

AIDS. 2013 Sep 10;27(14):2181-90. doi: 10.1097/QAD.0b013e3283639804.

17.

A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.

Yuan Y, Arnatt CK, El-Hage N, Dever SM, Jacob JC, Selley DE, Hauser KF, Zhang Y.

Medchemcomm. 2013 May 1;4(5):847-851.

18.

Subcutaneous administration of D-luciferin is an effective alternative to intraperitoneal injection in bioluminescence imaging of xenograft tumors in nude mice.

Khalil AA, Jameson MJ, Broaddus WC, Chung TD, Golding SE, Dever SM, Rosenberg E, Valerie K.

ISRN Mol Imaging. 2013;2013. pii: 689279.

19.

Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.

Fitting S, Scoggins KL, Xu R, Dever SM, Knapp PE, Dewey WL, Hauser KF.

Eur J Pharmacol. 2012 Aug 15;689(1-3):96-103. doi: 10.1016/j.ejphar.2012.05.029. Epub 2012 May 30.

20.

Opiate drug use and the pathophysiology of neuroAIDS.

Hauser KF, Fitting S, Dever SM, Podhaizer EM, Knapp PE.

Curr HIV Res. 2012 Jul;10(5):435-52. Review.

Supplemental Content

Loading ...
Support Center